Subject category:
Entrepreneurship
Published by:
Stanford Business School
Version: 4 June 2024
Revision date: 13-Feb-2025
Length: 29 pages
Data source: Field research
Share a link:
https://casecent.re/p/91799
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
'Note on the Biopharmaceutical Industry' explores the intricacies of the biopharmaceutical landscape, including the evolution from traditional pharmaceuticals to biotech and their convergence. It addresses the challenges of drug development, such as high costs, regulatory hurdles, and intellectual property issues, while highlighting innovations in gene therapy, biologics, and AI-driven solutions. The case provides insights into pricing and market access strategies, ethical concerns, and the industry's transformative role in improving health care outcomes.
Industry:
Other setting(s):
2003
About
Abstract
'Note on the Biopharmaceutical Industry' explores the intricacies of the biopharmaceutical landscape, including the evolution from traditional pharmaceuticals to biotech and their convergence. It addresses the challenges of drug development, such as high costs, regulatory hurdles, and intellectual property issues, while highlighting innovations in gene therapy, biologics, and AI-driven solutions. The case provides insights into pricing and market access strategies, ethical concerns, and the industry's transformative role in improving health care outcomes.
Settings
Industry:
Other setting(s):
2003